High-Yield Production of the Major Birch Pollen Allergen Bet v 1 With Allergen Immunogenicity in Nicotiana benthamiana
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
High-Yield Production of the Major Birch Pollen Allergen Bet v 1 With Allergen Immunogenicity in Nicotiana benthamiana
Authors
Keywords
-
Journal
Frontiers in Plant Science
Volume 11, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-04-02
DOI
10.3389/fpls.2020.00344
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Sublingual immunotherapy with the SQ tree SLIT-tablet is highly effective and well tolerated: results from a randomized, double-blind, placebo-controlled phase III trial
- (2019) Tilo Biedermann et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Comparison of microbial and transient expression (tobacco plants and plant‐cell packs) for the production and purification of the anti‐cancer mistletoe lectin viscumin
- (2019) Benjamin Bruno Gengenbach et al. BIOTECHNOLOGY AND BIOENGINEERING
- Agroinfiltration-based efficient transient protein expression in leguminous plants
- (2019) Takuya Suzaki et al. Plant Biotechnology
- Improvement of the transient expression system for production of recombinant proteins in plants
- (2018) Tsuyoshi Yamamoto et al. Scientific Reports
- Association analyses of eQTLs of the TYRO3 gene and allergic diseases in Japanese populations
- (2018) Jun Kanazawa et al. ALLERGOLOGY INTERNATIONAL
- Efficient transient protein expression in tomato cultivars and wild species using agroinfiltration-mediated high expression system
- (2018) Ken Hoshikawa et al. PLANT CELL REPORTS
- Expression and Characterization of Functional Recombinant Bet v 1.0101 in the Chloroplast of Chlamydomonas reinhardtii
- (2017) Sonja Hirschl et al. INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY
- Sensitization to PR-10 proteins is indicative of distinctive sensitization patterns in adults with a suspected food allergy
- (2017) Mark A. Blankestijn et al. Clinical and Translational Allergy
- IgE and allergen-specific immunotherapy-induced IgG4 recognize similar epitopes of Bet v 1, the major allergen of birch pollen
- (2016) N. Groh et al. CLINICAL AND EXPERIMENTAL ALLERGY
- Birch pollen immunotherapy inhibits anaphylaxis to the cross-reactive apple allergen Mal d 1 in mice
- (2016) L. Utsch et al. CLINICAL AND EXPERIMENTAL ALLERGY
- Measurement of health-related quality of life in adult patients with birch pollen-associated food allergy
- (2016) Susanne Beyer et al. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT
- Vaccine development for allergen-specific immunotherapy based on recombinant allergens and synthetic allergen peptides: Lessons from the past and novel mechanisms of action for the future
- (2016) Rudolf Valenta et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Overexpression of a Pathogenesis-Related Protein 10 Enhances Biotic and Abiotic Stress Tolerance in Rice
- (2016) Jingni Wu et al. Plant Pathology Journal
- Development and evaluation of a sublingual tablet based on recombinant Bet v 1 in birch pollen-allergic patients
- (2015) E. Nony et al. ALLERGY
- Molecular, proteomic and immunological parameters of allergens provide inclusion criteria for new candidates within established grass and tree homologous groups
- (2015) Matthew D Heath et al. World Allergy Organization Journal
- Mechanisms of allergen-specific immunotherapy: Multiple suppressor factors at work in immune tolerance to allergens
- (2014) Mübeccel Akdis et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp
- (2014) Xiangguo Qiu et al. NATURE
- Generation mechanism of novel, huge protein bodies containing wild type or hypoallergenic derivatives of birch pollen allergen Bet v 1 in rice endosperm
- (2014) Yuko Ogo et al. PLANT MOLECULAR BIOLOGY
- Genome-Wide Association Study for Levels of Total Serum IgE Identifies HLA-C in a Japanese Population
- (2013) Yohei Yatagai et al. PLoS One
- Birch pollen immunotherapy results in long-term loss of Bet v 1–specific TH2 responses, transient TR1 activation, and synthesis of IgE-blocking antibodies
- (2012) Christian Möbs et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- EAACI: A European Declaration on Immunotherapy. Designing the future of allergen specific immunotherapy
- (2012) Moises A Calderon et al. Clinical and Translational Allergy
- Functional rather than immunoreactive levels of IgG4 correlate closely with clinical response to grass pollen immunotherapy
- (2011) M. H. Shamji et al. ALLERGY
- Birch pollen–related food allergy: Clinical aspects and the role of allergen-specific IgE and IgG4 antibodies
- (2011) Marija Geroldinger-Simic et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Specific IgE antibodies in the diagnosis of atopic disease
- (2010) R. Paganelli et al. ALLERGY
- Brevibacillus Expression System: Host-Vector System for Efficient Production of Secretory Proteins
- (2010) Makoto Mizukami et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- Efficacy of recombinant birch pollen vaccine for the treatment of birch-allergic rhinoconjunctivitis
- (2008) Gabrielle Pauli et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started